Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2013

01.04.2013 | Gynecologic Oncology

Network motifs in the transcriptional regulation network of cervical carcinoma cells respond to EGF

verfasst von: Su Fang Wu, Wen Yan Qian, Jia Wen Zhang, Yong Bin Yang, Yuan Liu, Yu Dong, Zhen Bo Zhang, Ya Ping Zhu, You Ji Feng

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cervical carcinoma is the second most prevalent and the fifth most deadly malignancy seen in women worldwide. Dysregulated activation of EGF ErbB system has been implicated in diverse types of human cancer; however, it is elusive how it is regulated in human cervical cancer cells. We herein aimed to explore the mechanisms of cervical carcinoma response to epidermal growth factor (EGF), with a view of the pathways activated by EGF.

Methods

Using the GSE6783 affymetrix microarray data accessible from gene expression omnibus database, we first identified the differentially expressed genes between EGF-stimulated and -unstimulated samples. Then we constructed a regulation network and identified the network motifs. We also performed biological process and pathway enrichment analyses to functionally classify the genes in the regulation network.

Results

A total of 11 network motifs were identified in the regulation network. EGF treatment could increase the risk of cancer via dysregulation of cancer-related pathways and immune response pathways.

Conclusions

Network motif analysis is useful in mining the useful information underlying the network. We hope our work could serve as a basis for further experimentation.
Literatur
1.
Zurück zum Zitat Armstrong EP (2010) Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. J Manag Care Pharm 16(3):217–230PubMed Armstrong EP (2010) Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. J Manag Care Pharm 16(3):217–230PubMed
3.
4.
Zurück zum Zitat Brake T, Lambert PF (2005) Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci USA 102(7):2490–2495. doi:10.1073/pnas.0409883102 PubMedCrossRef Brake T, Lambert PF (2005) Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci USA 102(7):2490–2495. doi:10.​1073/​pnas.​0409883102 PubMedCrossRef
7.
Zurück zum Zitat Vignon F, Bouton MM, Rochefort H (1987) Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun 146(3):1502–1508, pii: 0006-291X(87)90819-9PubMedCrossRef Vignon F, Bouton MM, Rochefort H (1987) Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun 146(3):1502–1508, pii: 0006-291X(87)90819-9PubMedCrossRef
12.
Zurück zum Zitat Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, Zhang LV, Dupuy D, Walhout AJ, Cusick ME, Roth FP, Vidal M (2004) Evidence for dynamically organized modularity in the yeast protein–protein interaction network. Nature 430(6995):88–93. doi:10.1038/nature02555nature02555 PubMedCrossRef Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, Zhang LV, Dupuy D, Walhout AJ, Cusick ME, Roth FP, Vidal M (2004) Evidence for dynamically organized modularity in the yeast protein–protein interaction network. Nature 430(6995):88–93. doi:10.​1038/​nature02555natur​e02555 PubMedCrossRef
16.
Zurück zum Zitat Amit I, Citri A, Shay T, Lu Y, Katz M, Zhang F, Tarcic G, Siwak D, Lahad J, Jacob-Hirsch J, Amariglio N, Vaisman N, Segal E, Rechavi G, Alon U, Mills GB, Domany E, Yarden Y (2007) A module of negative feedback regulators defines growth factor signaling. Nat Genet 39(4):503–512. doi:10.1038/ng1987 PubMedCrossRef Amit I, Citri A, Shay T, Lu Y, Katz M, Zhang F, Tarcic G, Siwak D, Lahad J, Jacob-Hirsch J, Amariglio N, Vaisman N, Segal E, Rechavi G, Alon U, Mills GB, Domany E, Yarden Y (2007) A module of negative feedback regulators defines growth factor signaling. Nat Genet 39(4):503–512. doi:10.​1038/​ng1987 PubMedCrossRef
17.
Zurück zum Zitat Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis OV, Kloos DU, Land S, Lewicki-Potapov B, Michael H, Munch R, Reuter I, Rotert S, Saxel H, Scheer M, Thiele S, Wingender E (2003) TRANSFAC: transcriptional regulation, from patterns to profiles. Nucl Acids Res 31(1):374–378PubMedCrossRef Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis OV, Kloos DU, Land S, Lewicki-Potapov B, Michael H, Munch R, Reuter I, Rotert S, Saxel H, Scheer M, Thiele S, Wingender E (2003) TRANSFAC: transcriptional regulation, from patterns to profiles. Nucl Acids Res 31(1):374–378PubMedCrossRef
19.
Zurück zum Zitat Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3 (3). doi:10.2202/1544-6115.1027 Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3 (3). doi:10.​2202/​1544-6115.​1027
20.
Zurück zum Zitat Derrick TR, Bates BT, Dufek JS (1994) Evaluation of time-series data sets using the Pearson product-moment correlation coefficient. Med Sci Sports Exerc 26(7):919–928PubMed Derrick TR, Bates BT, Dufek JS (1994) Evaluation of time-series data sets using the Pearson product-moment correlation coefficient. Med Sci Sports Exerc 26(7):919–928PubMed
21.
24.
Zurück zum Zitat Brake T, Connor JP, Petereit DG, Lambert PF (2003) Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer. Cancer Res 63(23):8173–8180PubMed Brake T, Connor JP, Petereit DG, Lambert PF (2003) Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer. Cancer Res 63(23):8173–8180PubMed
25.
Zurück zum Zitat Mangan S, Zaslaver A, Alon U (2003) The coherent feedforward loop serves as a sign-sensitive delay element in transcription networks. J Mol Biol 334(2):197–204, pii: S0022283603012038PubMedCrossRef Mangan S, Zaslaver A, Alon U (2003) The coherent feedforward loop serves as a sign-sensitive delay element in transcription networks. J Mol Biol 334(2):197–204, pii: S0022283603012038PubMedCrossRef
26.
29.
Zurück zum Zitat Lee HP, Seo SS (2002) The application of human papillomavirus testing to cervical cancer screening. Yonsei Med J 43(6):763–768PubMed Lee HP, Seo SS (2002) The application of human papillomavirus testing to cervical cancer screening. Yonsei Med J 43(6):763–768PubMed
31.
Zurück zum Zitat Wang LW, Li Q, Hua ZL, Zhou F, Keping X, Daoyan W, Yao J, Ajani J (2007) Expression of transcription factor Sp1 in human gastric cancer tissue and its correlation with prognosis. Zhonghua Zhong Liu Za Zhi 29(2):107–111PubMed Wang LW, Li Q, Hua ZL, Zhou F, Keping X, Daoyan W, Yao J, Ajani J (2007) Expression of transcription factor Sp1 in human gastric cancer tissue and its correlation with prognosis. Zhonghua Zhong Liu Za Zhi 29(2):107–111PubMed
32.
Zurück zum Zitat Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F, Shen Y, Lu W, Wan X, Xie X (2011) miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am J Pathol 179(5):2580–2588. doi:10.1016/j.ajpath.2011.07.037 PubMedCrossRef Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F, Shen Y, Lu W, Wan X, Xie X (2011) miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am J Pathol 179(5):2580–2588. doi:10.​1016/​j.​ajpath.​2011.​07.​037 PubMedCrossRef
33.
Zurück zum Zitat Cho S, Cinghu S, Yu JR, Park WY (2011) Helicase-like transcription factor confers radiation resistance in cervical cancer through enhancing the DNA damage repair capacity. J Cancer Res Clin Oncol 137(4):629–637. doi:10.1007/s00432-010-0925-5 PubMedCrossRef Cho S, Cinghu S, Yu JR, Park WY (2011) Helicase-like transcription factor confers radiation resistance in cervical cancer through enhancing the DNA damage repair capacity. J Cancer Res Clin Oncol 137(4):629–637. doi:10.​1007/​s00432-010-0925-5 PubMedCrossRef
35.
Zurück zum Zitat Papassava P, Gorgoulis VG, Papaevangeliou D, Vlahopoulos S, van Dam H, Zoumpourlis V (2004) Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors. Cancer Res 64(23):8573–8584. doi:10.1158/0008-5472.CAN-03-0955 PubMedCrossRef Papassava P, Gorgoulis VG, Papaevangeliou D, Vlahopoulos S, van Dam H, Zoumpourlis V (2004) Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors. Cancer Res 64(23):8573–8584. doi:10.​1158/​0008-5472.​CAN-03-0955 PubMedCrossRef
Metadaten
Titel
Network motifs in the transcriptional regulation network of cervical carcinoma cells respond to EGF
verfasst von
Su Fang Wu
Wen Yan Qian
Jia Wen Zhang
Yong Bin Yang
Yuan Liu
Yu Dong
Zhen Bo Zhang
Ya Ping Zhu
You Ji Feng
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2013
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-012-2608-8

Weitere Artikel der Ausgabe 4/2013

Archives of Gynecology and Obstetrics 4/2013 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.